Cargando...
Belimumab in systemic lupus erythematosus: a perspective review
Belimumab (Benlysta(®)) is a fully humanized monoclonal antibody that inhibits B-lymphocyte stimulator (also known as B cell activating factor of the tumor necrosis factor family) and was approved by the US Food and Drug Administration and the European Medicines Evaluation Agency for treatment of au...
Gardado en:
| Publicado en: | Ther Adv Musculoskelet Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530384/ https://ncbi.nlm.nih.gov/pubmed/26288663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X15588514 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|